Literature DB >> 11564658

Hydrogen peroxide-mediated inhibition of lipopolysaccharide-stimulated inhibitory kappa B kinase activity in rat aortic smooth muscle cells.

L J Torrie1, C J MacKenzie, A Paul, R Plevin.   

Abstract

1. In rat aortic smooth muscle cells (RASMC), exposure to lipopolysaccharide (LPS) resulted in NF-kappaB-DNA binding, degradation of IkappaB-alpha, -beta and -epsilon and increased activity of both alpha and beta isoforms of inhibitory kappa B kinase (IKK). 2. Expression of dominant-negative (DN)-IKK-alpha, IKK-beta and NF-kappaB-inducing kinase (NIK) abolished LPS-stimulated NF-kappaB reporter activity, suggesting that activation of a NIK/IKK-dependent pathway is indispensable for NF-kappaB activation by LPS in this cell type. 3. The tyrosine phosphatase inhibitor, pervanadate, abolished LPS-stimulated NF-kappaB-DNA-binding activity. However, the effect of pervanadate was shown to be mediated by excess hydrogen peroxide (H(2)O(2)) present in the reaction mix. Preincubation of RASMC with H(2)O(2) inhibited LPS-stimulated IKK kinase activity and downstream NF-kappaB-DNA binding activity. 4. H(2)O(2) also strongly stimulated p38 MAP kinase activity in RASMCs. Effective inhibition of this pathway using SB203580 did not reverse the effects of H(2)O(2) on LPS-stimulated IKK/NF-kappaB signalling. 5. These studies show that hydrogen peroxide-mediated inhibition of LPS-stimulated NF-kappaB activation in RASMC occurs upstream of IKK. The inhibitory effect of H(2)O(2) is not due to tyrosine phosphatase inhibition, it is mediated by H(2)O(2) through a mechanism which is independent of any cross-talk involving MAP kinase homologues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564658      PMCID: PMC1572956          DOI: 10.1038/sj.bjp.0704259

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  67 in total

1.  Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras.

Authors:  J Abe; M Okuda; Q Huang; M Yoshizumi; B C Berk
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

2.  Differential effects of lipopolysaccharide and tumor necrosis factor on monocytic IkappaB kinase signalsome activation and IkappaB proteolysis.

Authors:  C Fischer; S Page; M Weber; T Eisele; D Neumeier; K Brand
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

3.  JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?

Authors:  M Karin; M Delhase
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

4.  Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions.

Authors:  A O'Mahony; X Lin; R Geleziunas; W C Greene
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor, I-kappaB.

Authors:  S Hoshi; M Goto; N Koyama; K Nomoto; H Tanaka
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

6.  IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases.

Authors:  T Shimada; T Kawai; K Takeda; M Matsumoto; J Inoue; Y Tatsumi; A Kanamaru; S Akira
Journal:  Int Immunol       Date:  1999-08       Impact factor: 4.823

7.  Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation.

Authors:  D Alpert; P Schwenger; J Han; J Vilcek
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

Review 8.  Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries.

Authors:  A Bowie; L A O'Neill
Journal:  Biochem Pharmacol       Date:  2000-01-01       Impact factor: 5.858

9.  Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases.

Authors:  R Geleziunas; S Ferrell; X Lin; Y Mu; E T Cunningham; M Grant; M A Connelly; J E Hambor; K B Marcu; W C Greene
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV.

Authors:  K Bender; M Göttlicher; S Whiteside; H J Rahmsdorf; P Herrlich
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

View more
  5 in total

1.  Selective inhibition of inhibitory kappa B kinase-beta abrogates induction of nitric oxide synthase in lipopolysaccharide-stimulated rat aortic smooth muscle cells.

Authors:  Almudena Bermejo Gomez; Christopher MacKenzie; Andrew Paul; Robin Plevin
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

2.  Enhancement of lipopolysaccharide-stimulated JNK activity in rat aortic smooth muscle cells by pharmacological and adenovirus-mediated inhibition of inhibitory kappa B kinase signalling.

Authors:  Christopher J MacKenzie; Andrew Paul; Susan Wilson; Rainer de Martin; Andrew H Baker; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

3.  Inhibition of pacemaker activity in interstitial cells of Cajal by LPS via NF-κB and MAP kinase.

Authors:  Dong Chuan Zuo; Seok Choi; Pawan Kumar Shahi; Man Yoo Kim; Chan Guk Park; Young Dae Kim; Jun Lee; In Yeoup Chang; Insuk So; Jae Yeoul Jun
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

4.  Modulation of SCF beta-TrCP-dependent I kappaB alpha ubiquitination by hydrogen peroxide.

Authors:  Sami Banerjee; Jaroslaw W Zmijewski; Emmanuel Lorne; Gang Liu; Yonggang Sha; Edward Abraham
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

5.  Reactive Oxygen Species Differentially Regulate Bone Turnover in an Age-Specific Manner in Catalase Transgenic Female Mice.

Authors:  Alexander W Alund; Kelly E Mercer; Larry J Suva; Casey F Pulliam; Jin-Ran Chen; Thomas M Badger; Holly Van Remmen; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2016-05-12       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.